$36.54
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

CONMED Corp. is a medical technology company, which engages in providing devices and equipment for surgical procedures. The company is headquartered in Largo, Florida and currently employs 3,900 full-time employees. Its products are used by surgeons and other healthcare professionals in a variety of specialties, including orthopedics, general surgery, gynecology, thoracic surgery and gastroenterology. Its product lines consist of orthopedic surgery and general surgery. Orthopedic surgery consists of sports medicine instrumentation and lower extremities instrumentation and implants, small bone, large bone and specialty-powered surgical instruments as well as imaging systems for use in minimally invasive surgical procedures and service fees related to the promotion and marketing of sports medicine allograft tissue. General surgery consists of a complete line of endo-mechanical instrumentation for minimally invasive laparoscopic and gastrointestinal procedures, smoke evacuation devices, a line of cardiac monitoring products as well as electrosurgical generators and related instruments.
Country

US

CEO

Mr. Patrick Beyer

IPO date

1987

Employees

3,900

ISIN

US2074101013

Key stats

Open

$36.69

Volume

1.18M

Market cap

$1.01B

Prev. close

$36.69

Impl / hst vl

-

Open interest

$0.00

$36.54

Day’s Range

$38.00

$31.44

52W Range

$47.08

Valuation

55
Valuation score
Fairly Valued
P/E
18.41
P/S
0.74
P/B
0.99
Current ratio
2.29
Debt / Equity
0.81
ROE
5.40%
Gross margin
57.86%
Income growth
-17.39%
FCF growth
-74.34

Oct

3

Dividends

The last payment date was Oct 3, 2025

Div. per Share

$0.20

Div. Yield

0.60%

Payout Ratio

39.73%

Div. Growth YoY

0.00%

Analysts estimates

Consensus rating
Hold

The average rating from top 7 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$40.29
The top 7 analysts forecasts that 12-month price may increase by 10.26%, with a low of $39.39 and a high of $42.00
$39.39
Low
$40.29
Avg
$42.00
High
Current price

Earnings

Q1 ‘26 revenue
$317.05M
Q1 ‘26 net income
$13.83M
Revenue
Net income
Previous EPS
$0.89
Estimate EPS
$1.13
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply